evaluation long term tobramycin therapy patient cystic fibrosis advanced pulmonary disease nine cystic fibrosis patient chronic bronchopulmonary infection severely damaged lung invaded pseudomonas aeruginosa eleven course prolonged tobramycin treatment 5 mgkgday four 16 week administered pulmonary symptom improved better quality life achieved one patient objective parameter chest xray pulmonary function test changed lesser extent one patient pseudomonas eradicated sputum reappeared discontinuation therapy rest patient pseudomonas significantly suppressed replaced pathogen four patient showed rise antibody titre candida two aspergillus fumigatus nephrotoxic side effect observed vestibular function reversibly impaired one patient without corresponding clinical symptom bacterial resistance tobramycin observed therapy